The Point of Care (PoC) Lipid Test Market is expected to register a CAGR of 4.5% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report is categorized by product type into the following subsegments: Devices and Consumables. It further presents an analysis based on test type, including Total Cholesterol Tests, Triglyceride Tests, LDL Tests, HDL Tests, and Combined Lipid Panel Tests. Additionally, The report evaluates end-users such as Hospitals, Clinics, Diagnostic Laboratories, and Homecare Settings.
The global analysis is broken down at the regional level and major countries, covering key regions like North America, Europe, Asia Pacific, the Middle East & Africa, and South America. The market evaluation is presented in US$ for the above segmental analysis.
The report Point of Care (PoC) Lipid Test Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Point of Care (PoC) Lipid Test Market Segmentation
Product- Instruments
- Consumables
- Hypertriglyceridemia
- Hyperlipidemia
- Hyperlipoproteinemia
- Familial Hypercholesterolemia
- Tangier Disease
- Hospitals
- Research and Diagnostic Laboratories
Strategic Insights
Point of Care (PoC) Lipid Test Market Growth Drivers- Growing Incidence of CVDs: The fastest-growing category for the expansion of the Chromatography Resin Point of Care (PoC) Lipid Test Market is the rising incidence of cardiovascular diseases (CVDs). According to World Health Federation, CVD was the leading cause of death globally in 2021 with 4 in every 5 deaths caused by CVD occurring in low-and-middle-income countries. The most common CVDs are heart disease, stroke, and hypertension, which are also the leading causes of death around the world. According to the WHO, CVDs account for 31% of deaths globally; therefore, preventive measures and early detection become important considerations in healthcare. Lipid profiling, which consists of cholesterol profiles, is crucial for determining CVD risk factors. Rapid detection and monitoring of lipid levels are crucial for the early diagnosis and treatment of conditions. The Point-of-care testing devices offer the benefit of rapid results without the need for patients to visit laboratories or wait for lengthy processing times. Lipid testing has become a convenient and essential tool in the fight against heart disease, especially in regions with a high burden of lifestyle-related CVDs.
- Increased Focus on Preventative Healthcare: According to the Office of Disease Prevention and Health Promotion, prevention is still the best medicine. In recent years, there has been a trend towards preventative healthcare, with a greater focus on early detection and proactive management of health conditions. As people are becoming more health-conscious and avoid the costs and complications associated with chronic diseases, there is an increased demand for regular health monitoring, including lipid testing. Cholesterol-related heart disease has become so pervasive that people are paying attention to lipid levels in hopes of preventing the occurrence of diseases like atherosclerosis, hypertension, and heart attacks. The PoC lipid test in itself becomes perfectly aligned with this preventive care focus since it lets a person follow up on their cholesterol levels regularly and make necessary lifestyle or prescription changes.
- Advancement in Technology: The market for point-of-care testing (PoC) has developed very well, particularly concerning technologies allowing rapid analysis. This means the possibility of lipid testing can be achieved through PoC devices directly at the point of care, which might be located in a physician's office, pharmacy, or even at home. Moreover, it does not require patients to go to the laboratory. POC devices provide healthcare professionals with the ability to perform tests and obtain clear results. This saves money on healthcare services and promotes better patient compliance by allowing early intervention. Advances in PoC lipid testing technology include enhanced sensitivity, specificity, and accuracy. The fact that the PoC devices are portable, user-friendly, and provide results instantly is further helping to drive adoption among both healthcare providers and patients. The trend of reducing hospital visits, especially in the recent times of COVID-19, triggers enhanced demand for PoC lipid tests. As these devices become more advanced, affordable, and accessible, their use in the clinical and home setting is bound to experience significant growth.
- Miniaturization of Diagnostic Devices: One of the commanding trends in the PoC lipid testing market is the miniaturization of diagnostic devices. Miniaturized devices are preferred more as they are Compact, portable, user-friendly, and reasonably priced. These machines have made access to performing a lipid test out of a traditional laboratory setting much easier than ever. Miniature devices have particularly become appealing because professionals outside of direct medical care can use them. These professionals prefer smaller and simple-to-use tools that require no minimal training. The trend toward miniaturization is driven by advances in microelectronics, sensors, and fluid handling technologies, which allow for the integration of sophisticated diagnostic capabilities into small, handheld devices. This trend is very important because it extends access to lipid testing to people who cannot reach traditional health facilities, especially in rural or remote areas.
- Integration with Digital Health: As digital health technologies continue to evolve, the integration of PoC lipid testing devices with digital platforms is an important trend.
This trend towards the implementation of PoC technologies includes devices equipped with Bluetooth, smartphones, and cloud systems for connectivity. Using these technologies will allow users to track their results over time share information with healthcare professionals and access personalized recommendations for improvement connected to their own lipid profile. This trend corresponds to the more general push towards digital health; data from wearable devices, home-testing kits, and other health technologies are increasingly deployed in monitoring chronic conditions remotely. To healthcare practitioners, this means real-time access to patient test data will promote better decision-making, enabling enhanced treatment plans for patients. - Increased Regulatory Approvals: The regulatory environment for PoC testing devices is changing, with many countries revising their policies in support of the approval and commercialization of innovative diagnostic tools. Regulatory bodies such as the U.S.
The FDA, EMA, and others have been increasingly appreciating the value of PoC tests in improving access to health care and enhancing outcomes. In recent years, the approval of PoC lipid test devices has gradually increased, and manufacturers are being made to meet rigorous quality standards and safety requirements. These approvals are an important factor in market growth as they instill confidence in consumers and health care providers.
- Expanding into Rural and Underserved Areas: This is a very significant opportunity for market growth by expanding PoC lipid testing to rural and underserved areas. Many regions, especially in low- and middle-income countries, are not equipped with high-end healthcare infrastructure, including diagnostic laboratories for lipid testing. The PoC device can bridge the gap by offering affordable, portable, and easy-to-use alternatives that can be deployed in remote locations. Mobile health units, pharmacies, and local clinics can be used as points of care for these devices, providing much-needed services to underserved populations. Beyond expanding access to healthcare, PoC lipid tests also provide a cost-effective solution, which is important in areas with limited healthcare budgets. This opportunity is further enhanced by the growing awareness of the importance of lipid testing in the prevention of heart disease and other cardiovascular conditions. By offering these services in rural or underserved areas, companies can tap into a large, untapped market and contribute to improving global health outcomes.
- Growth in demand for cost-effectiveness: In the Asia-Pacific, Latin America, and Africa regions, healthcare demand is growing as incomes rise and populations age. Lifestyle-related diseases, such as hypertension, diabetes, and cardiovascular conditions, are on the rise in these regions, making lipid testing an integral part of healthcare monitoring. PoC lipid testing devices are an ideal solution for these markets as they provide a cost-effective, quick, and reliable means of assessing cholesterol levels without the need for expensive infrastructure. As awareness of the importance of regular lipid testing grows in emerging markets, the demand for PoC devices is expected to increase. This opportunity can be realized by companies entering these markets through offering cost-effective, culture-sensitive PoC lipid testing solutions that cater to local needs, through collaboration with the local government and health organizations, as well as significant distribution networks to facilitate the growth of these technologies in emerging markets.
- Expanding portfolios of diagnostic kits: Multi-disease testing kit opportunities can be found by companies operating in the PoC testing market. These kits may also integrate lipid testing with other key health checks, for example, on blood glucose or inflammation markers. With this combination, one measures various health indicators all at once, which is useful for people prone to cardiovascular disease, diabetes, and related metabolic conditions. Package tests under different products enables companies to present greater value compared to the individual test, likely prompting consumers to buy comprehensive health monitoring solutions. These all-in-one test kits can appeal also to health care professionals looking to add to their point of care holistic screen services. Growing portfolios of diagnostic tests also afford companies the chance to enter a new market with increased market shares through the opportunity to meet many different consumer needs.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Point of Care (PoC) Lipid Test Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Point of Care (PoC) Lipid Test Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Chromatography Resin Point of Care (PoC) Lipid Test Market is expected to register a CAGR of 4.5% from 2025-2031.
The major factors impacting the Chromatography Resin Point of Care (PoC) Lipid Test Market are: Growing incidences of CVD, Preventive Approaches, and Advanced technologies.
Key future trends in the Chromatography Resin Point of Care (PoC) Lipid Test market are - Miniaturization, integration of digital health, and increaseed regulatory approvals
Key companies of Chromatography Resin Point of Care (PoC) Lipid Test market are: F. Hoffmann-La Roche Ltd, Abbott, Abaxis, iXensor, PTS Diagnostics, ACON Laboratories, Inc, A. Menarini Diagnostics s.r.l, EuroMedix Health am Dom GmbH, Bio-Rad Laboratories, Inc, Nova Biomedical
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Point Of Care (PoC) Lipid Test Market - By Product
1.3.2 Point Of Care (PoC) Lipid Test Market - By Application
1.3.3 Point Of Care (PoC) Lipid Test Market - By End User
1.3.4 Point Of Care (PoC) Lipid Test Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POINT OF CARE (POC) LIPID TEST MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. POINT OF CARE (POC) LIPID TEST MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. POINT OF CARE (POC) LIPID TEST MARKET - GLOBAL MARKET ANALYSIS
6.1. POINT OF CARE (POC) LIPID TEST - GLOBAL MARKET OVERVIEW
6.2. POINT OF CARE (POC) LIPID TEST - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. POINT OF CARE (POC) LIPID TEST MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
8. POINT OF CARE (POC) LIPID TEST MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPERTRIGLYCERIDEMIA
8.3.1. Overview
8.3.2. Hypertriglyceridemia Market Forecast and Analysis
8.4. HYPERLIPIDEMIA
8.4.1. Overview
8.4.2. Hyperlipidemia Market Forecast and Analysis
8.5. HYPERLIPOPROTEINEMIA
8.5.1. Overview
8.5.2. Hyperlipoproteinemia Market Forecast and Analysis
8.6. FAMILIAL HYPERCHOLESTEROLEMIA
8.6.1. Overview
8.6.2. Familial Hypercholesterolemia Market Forecast and Analysis
8.7. TANGIER DISEASE
8.7.1. Overview
8.7.2. Tangier Disease Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. POINT OF CARE (POC) LIPID TEST MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RESEARCH AND DIAGNOSTIC LABORATORIES
9.4.1. Overview
9.4.2. Research and Diagnostic Laboratories Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. POINT OF CARE (POC) LIPID TEST MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Point Of Care (PoC) Lipid Test Market Overview
10.1.2 North America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis
10.1.3 North America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Product
10.1.4 North America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Application
10.1.5 North America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By End User
10.1.6 North America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Countries
10.1.6.1 United States Point Of Care (PoC) Lipid Test Market
10.1.6.1.1 United States Point Of Care (PoC) Lipid Test Market by Product
10.1.6.1.2 United States Point Of Care (PoC) Lipid Test Market by Application
10.1.6.1.3 United States Point Of Care (PoC) Lipid Test Market by End User
10.1.6.2 Canada Point Of Care (PoC) Lipid Test Market
10.1.6.2.1 Canada Point Of Care (PoC) Lipid Test Market by Product
10.1.6.2.2 Canada Point Of Care (PoC) Lipid Test Market by Application
10.1.6.2.3 Canada Point Of Care (PoC) Lipid Test Market by End User
10.1.6.3 Mexico Point Of Care (PoC) Lipid Test Market
10.1.6.3.1 Mexico Point Of Care (PoC) Lipid Test Market by Product
10.1.6.3.2 Mexico Point Of Care (PoC) Lipid Test Market by Application
10.1.6.3.3 Mexico Point Of Care (PoC) Lipid Test Market by End User
10.2. EUROPE
10.2.1 Europe Point Of Care (PoC) Lipid Test Market Overview
10.2.2 Europe Point Of Care (PoC) Lipid Test Market Forecasts and Analysis
10.2.3 Europe Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Product
10.2.4 Europe Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Application
10.2.5 Europe Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By End User
10.2.6 Europe Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Point Of Care (PoC) Lipid Test Market
10.2.6.1.1 Germany Point Of Care (PoC) Lipid Test Market by Product
10.2.6.1.2 Germany Point Of Care (PoC) Lipid Test Market by Application
10.2.6.1.3 Germany Point Of Care (PoC) Lipid Test Market by End User
10.2.6.2 France Point Of Care (PoC) Lipid Test Market
10.2.6.2.1 France Point Of Care (PoC) Lipid Test Market by Product
10.2.6.2.2 France Point Of Care (PoC) Lipid Test Market by Application
10.2.6.2.3 France Point Of Care (PoC) Lipid Test Market by End User
10.2.6.3 Italy Point Of Care (PoC) Lipid Test Market
10.2.6.3.1 Italy Point Of Care (PoC) Lipid Test Market by Product
10.2.6.3.2 Italy Point Of Care (PoC) Lipid Test Market by Application
10.2.6.3.3 Italy Point Of Care (PoC) Lipid Test Market by End User
10.2.6.4 Spain Point Of Care (PoC) Lipid Test Market
10.2.6.4.1 Spain Point Of Care (PoC) Lipid Test Market by Product
10.2.6.4.2 Spain Point Of Care (PoC) Lipid Test Market by Application
10.2.6.4.3 Spain Point Of Care (PoC) Lipid Test Market by End User
10.2.6.5 United Kingdom Point Of Care (PoC) Lipid Test Market
10.2.6.5.1 United Kingdom Point Of Care (PoC) Lipid Test Market by Product
10.2.6.5.2 United Kingdom Point Of Care (PoC) Lipid Test Market by Application
10.2.6.5.3 United Kingdom Point Of Care (PoC) Lipid Test Market by End User
10.2.6.6 Rest of Europe Point Of Care (PoC) Lipid Test Market
10.2.6.6.1 Rest of Europe Point Of Care (PoC) Lipid Test Market by Product
10.2.6.6.2 Rest of Europe Point Of Care (PoC) Lipid Test Market by Application
10.2.6.6.3 Rest of Europe Point Of Care (PoC) Lipid Test Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Point Of Care (PoC) Lipid Test Market Overview
10.3.2 Asia-Pacific Point Of Care (PoC) Lipid Test Market Forecasts and Analysis
10.3.3 Asia-Pacific Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Point Of Care (PoC) Lipid Test Market
10.3.6.1.1 Australia Point Of Care (PoC) Lipid Test Market by Product
10.3.6.1.2 Australia Point Of Care (PoC) Lipid Test Market by Application
10.3.6.1.3 Australia Point Of Care (PoC) Lipid Test Market by End User
10.3.6.2 China Point Of Care (PoC) Lipid Test Market
10.3.6.2.1 China Point Of Care (PoC) Lipid Test Market by Product
10.3.6.2.2 China Point Of Care (PoC) Lipid Test Market by Application
10.3.6.2.3 China Point Of Care (PoC) Lipid Test Market by End User
10.3.6.3 India Point Of Care (PoC) Lipid Test Market
10.3.6.3.1 India Point Of Care (PoC) Lipid Test Market by Product
10.3.6.3.2 India Point Of Care (PoC) Lipid Test Market by Application
10.3.6.3.3 India Point Of Care (PoC) Lipid Test Market by End User
10.3.6.4 Japan Point Of Care (PoC) Lipid Test Market
10.3.6.4.1 Japan Point Of Care (PoC) Lipid Test Market by Product
10.3.6.4.2 Japan Point Of Care (PoC) Lipid Test Market by Application
10.3.6.4.3 Japan Point Of Care (PoC) Lipid Test Market by End User
10.3.6.5 South Korea Point Of Care (PoC) Lipid Test Market
10.3.6.5.1 South Korea Point Of Care (PoC) Lipid Test Market by Product
10.3.6.5.2 South Korea Point Of Care (PoC) Lipid Test Market by Application
10.3.6.5.3 South Korea Point Of Care (PoC) Lipid Test Market by End User
10.3.6.6 Rest of Asia-Pacific Point Of Care (PoC) Lipid Test Market
10.3.6.6.1 Rest of Asia-Pacific Point Of Care (PoC) Lipid Test Market by Product
10.3.6.6.2 Rest of Asia-Pacific Point Of Care (PoC) Lipid Test Market by Application
10.3.6.6.3 Rest of Asia-Pacific Point Of Care (PoC) Lipid Test Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Point Of Care (PoC) Lipid Test Market Overview
10.4.2 Middle East and Africa Point Of Care (PoC) Lipid Test Market Forecasts and Analysis
10.4.3 Middle East and Africa Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Point Of Care (PoC) Lipid Test Market
10.4.6.1.1 South Africa Point Of Care (PoC) Lipid Test Market by Product
10.4.6.1.2 South Africa Point Of Care (PoC) Lipid Test Market by Application
10.4.6.1.3 South Africa Point Of Care (PoC) Lipid Test Market by End User
10.4.6.2 Saudi Arabia Point Of Care (PoC) Lipid Test Market
10.4.6.2.1 Saudi Arabia Point Of Care (PoC) Lipid Test Market by Product
10.4.6.2.2 Saudi Arabia Point Of Care (PoC) Lipid Test Market by Application
10.4.6.2.3 Saudi Arabia Point Of Care (PoC) Lipid Test Market by End User
10.4.6.3 U.A.E Point Of Care (PoC) Lipid Test Market
10.4.6.3.1 U.A.E Point Of Care (PoC) Lipid Test Market by Product
10.4.6.3.2 U.A.E Point Of Care (PoC) Lipid Test Market by Application
10.4.6.3.3 U.A.E Point Of Care (PoC) Lipid Test Market by End User
10.4.6.4 Rest of Middle East and Africa Point Of Care (PoC) Lipid Test Market
10.4.6.4.1 Rest of Middle East and Africa Point Of Care (PoC) Lipid Test Market by Product
10.4.6.4.2 Rest of Middle East and Africa Point Of Care (PoC) Lipid Test Market by Application
10.4.6.4.3 Rest of Middle East and Africa Point Of Care (PoC) Lipid Test Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Point Of Care (PoC) Lipid Test Market Overview
10.5.2 South and Central America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis
10.5.3 South and Central America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Product
10.5.4 South and Central America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Application
10.5.5 South and Central America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By End User
10.5.6 South and Central America Point Of Care (PoC) Lipid Test Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Point Of Care (PoC) Lipid Test Market
10.5.6.1.1 Brazil Point Of Care (PoC) Lipid Test Market by Product
10.5.6.1.2 Brazil Point Of Care (PoC) Lipid Test Market by Application
10.5.6.1.3 Brazil Point Of Care (PoC) Lipid Test Market by End User
10.5.6.2 Argentina Point Of Care (PoC) Lipid Test Market
10.5.6.2.1 Argentina Point Of Care (PoC) Lipid Test Market by Product
10.5.6.2.2 Argentina Point Of Care (PoC) Lipid Test Market by Application
10.5.6.2.3 Argentina Point Of Care (PoC) Lipid Test Market by End User
10.5.6.3 Rest of South and Central America Point Of Care (PoC) Lipid Test Market
10.5.6.3.1 Rest of South and Central America Point Of Care (PoC) Lipid Test Market by Product
10.5.6.3.2 Rest of South and Central America Point Of Care (PoC) Lipid Test Market by Application
10.5.6.3.3 Rest of South and Central America Point Of Care (PoC) Lipid Test Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. POINT OF CARE (POC) LIPID TEST MARKET, KEY COMPANY PROFILES
12.1. F. HOFFMANN-LA ROCHE LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABAXIS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IXENSOR
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PTS DIAGNOSTICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ACON LABORATORIES, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. A. MENARINI DIAGNOSTICS S.R.L
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EUROMEDIX HEALTH AM DOM GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIO-RAD LABORATORIES, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVA BIOMEDICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. F. Hoffmann-La Roche Ltd
2. Abbott
3. Abaxis
4. iXensor
5. PTS Diagnostics
6. ACON Laboratories, Inc
7. A. Menarini Diagnostics s.r.l
8. EuroMedix Health am Dom GmbH
9. Bio-Rad Laboratories, Inc
10. Nova Biomedical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For